Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Audits Of 340B Providers Will Be Both Random And Targeted, HRSA Says

This article was originally published in The Pink Sheet Daily

Executive Summary

The Health Resources and Services Administration has begun random and targeted audits of health care providers participating in the federal 340B drug discount program to help ensure products are not being diverted for other uses or resulting in manufacturers paying double discounts to Medicaid.

You may also be interested in...



Senior Senators Seek Details On Government Audits Of 340B Entities

Top Republicans on two Senate health committees are joined by House members in seeking answers on an HHS review of entities receiving 340B drug discounts, including the process and consequences of audits and decertification.

340B Drug Audits: HRSA Reviewing 51 Entities In 2012

In its first year of auditing 340B facilities for compliance with drug discount rules, the HHS agency is investigating 45 randomly selected entities and six “targeted” entities that are the subject of specific allegations of non-compliance. About 250 hospitals have been decertified from 340B and may have to pay back discounts to drug makers.

ACOs Can’t Tap Into 340B Drug Discounts Provided To Member Safety Net Facilities, HRSA Clarifies

The clarification could answer biopharma industry concerns about how 340B rules fit in the new Medicare accountable care organization program; HRSA also advises that drug shortage allocation plans may not discriminate against 340 providers.

Related Content

Topics

UsernamePublicRestriction

Register

PS073848

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel